MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 64 filers reported holding MEI PHARMA INC in Q3 2018. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $218,000 | -7.6% | 78,958 | -4.7% | 0.01% | -25.0% |
| Q2 2021 | $236,000 | +49.4% | 82,818 | +80.2% | 0.01% | +33.3% |
| Q1 2021 | $158,000 | +81.6% | 45,965 | +40.2% | 0.01% | +100.0% |
| Q4 2020 | $87,000 | +64.2% | 32,776 | +92.4% | 0.00% | 0.0% |
| Q3 2020 | $53,000 | +76.7% | 17,037 | -8.9% | 0.00% | +50.0% |
| Q1 2020 | $30,000 | +20.0% | 18,700 | +87.0% | 0.00% | 0.0% |
| Q4 2019 | $25,000 | -79.0% | 10,000 | -74.1% | 0.00% | -83.3% |
| Q1 2019 | $119,000 | -38.0% | 38,667 | -46.7% | 0.01% | -57.1% |
| Q4 2018 | $192,000 | +204.8% | 72,594 | +392.9% | 0.03% | +366.7% |
| Q3 2018 | $63,000 | +117.2% | 14,729 | +21.4% | 0.01% | 0.0% |
| Q2 2017 | $29,000 | 0.0% | 12,135 | -33.0% | 0.01% | +20.0% |
| Q1 2017 | $29,000 | – | 18,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |